首页> 外文期刊>American Journal of Epidemiology and Infectious Disease >Retrospective Cross-sectional Study of Dengue Cases in IPD with Reference to Treatment- Monitoring & Outcome in KEM Hospital, Mumbai
【24h】

Retrospective Cross-sectional Study of Dengue Cases in IPD with Reference to Treatment- Monitoring & Outcome in KEM Hospital, Mumbai

机译:孟买KEM医院的IPD登革热病例回顾性横断面研究(参考治疗监测和结果)

获取原文
           

摘要

Dengue is the most important vector-borne viral disease of humans and likely more important than malaria globally in terms of morbidity and economic impact [8]. Transmission of dengue is now present in every region of the world and more than 125 countries are known to be dengue endemic. Maharashtra has the highest dengue mortality rate (3.4%) in India, as per data obtained from National Vector Borne Diseases Control Program (NVBDCP-2013). The case fatality rate is significantly high as compared that with other infectious diseases. This observational study was done to obtain the information on treatment given & its outcome in clinical profile & also to assess treatment gap & outcome of Dengue patients admitted in KEM Hospital. The data was collected from the case records of dengue diagnosed patients from Medical record department and it was filled in case record form. The statistical-analysis & the conclusion were drawn with the help of observations. The study revealed that maximum number (121) of dengue cases were in the age group of 21-30 yrs. There was an association between platelet count and treatment outcome. Severity in sign & symptoms lead to complication (n=23) and death (n= 21) in dengue cases. There were 22 deaths occurred in year 2013 because of dengue. Out of which maximum 12 cases reported in months of September (n=6) & October (n=6). There was no treatment gap found in cases of Deaths in study but 36% of died patients received antimalarial treatment even after diagnosed with Dengue. Remaining 64% of died patients received appropriate, rational and life saving treatment for dengue.
机译:登革热是人类最重要的媒介传播病毒性疾病,就发病率和经济影响而言,登革热在全球范围内可能比疟疾更为重要[8]。登革热的传播现在在世界每个地区都存在,已知有125个以上的国家是登革热的地方病。根据国家媒介传染病控制计划(NVBDCP-2013)获得的数据,马哈拉施特拉邦的印度登革热死亡率最高(3.4%)。与其他传染病相比,病死率显着高。进行这项观察性研究的目的是获得有关给定治疗方法及其临床概况的信息,并评估在KEM医院住院的登革热患者的治疗差距和结果。这些数据是从病历部门的登革热诊断患者的病历中收集的,并填写在病历表中。借助观察得出统计分析和结论。研究显示,登革热病例的最大数量为121到21至30岁。血小板计数与治疗结果之间存在关联。在登革热病例中,严重的症状和体征会导致并发症(n = 23)和死亡(n = 21)。 2013年,有22人死于登革热。在9月(n = 6)和10月(n = 6)的月份中,最多报告12例。在研究的死亡病例中没有发现治疗差距,但即使确诊登革热,也有36%的死亡患者接受了抗疟疾治疗。其余64%的死亡患者接受了适当,合理和挽救生命的登革热治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号